New Merck and Moderna vaccine extends lifespan of people living with deadliest form of skin cancer
The shot is combined with Keytruda - an immunotherapy drug used to treat cancer - and slashes the risk of death and melanoma returning by 49 percent.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.dailymail.co.uk — the content belongs to Daily Mail Health.